HomeGeneticsConditionHereditary pancreatitis
Back to Condition
Hereditary pancreatitis
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Hereditary pancreatitis

Hereditary pancreatitis is a rare genetic condition characterized by recurrent episodes of pancreatic inflammation that can lead to permanent tissue damage, loss of organ function, and an increased risk of pancreatic cancer.

Overview and Symptoms

The pancreas produces enzymes that help digest food, and it also produces insulin, a hormone that controls levels of blood glucose (blood sugar). In individuals with hereditary pancreatitis, recurrent episodes of inflammation can lead to permanent tissue damage and loss of pancreatic function.

Signs and symptoms usually begin in late childhood with an episode of acute pancreatitis. A sudden (acute) attack can cause abdominal pain, fever, nausea, or vomiting. An episode typically lasts from one to three days, though some people experience severe episodes that last longer. The condition progresses to recurrent acute pancreatitis, defined as multiple episodes recurring over a period of at least a year. The number of episodes varies per person.

Recurrent acute pancreatitis leads to chronic pancreatitis, which occurs when the pancreas is persistently inflamed. Chronic pancreatitis usually develops by early adulthood. Symptoms include occasional or frequent abdominal pain of varying severity, flatulence, and bloating. Many affected individuals also develop abnormal calcium deposits in the pancreas (pancreatic calcifications) by early adulthood.

Years of inflammation damage the pancreas, causing the formation of scar tissue (fibrosis) in place of functioning pancreatic tissue. This loss of function can impair the production of digestive enzymes and disrupt normal digestion, leading to:

  • Fatty stool (steatorrhea)
  • Weight loss
  • Protein and vitamin deficiencies

Because of a decrease in insulin production due to the loss of pancreatic function, about a quarter of individuals with hereditary pancreatitis will develop type 1 diabetes mellitus by mid-adulthood. The risk of developing diabetes increases with age.

Complications and Prognosis

Chronic pancreatic inflammation and damage to the pancreas increase the risk of developing pancreatic cancer. This risk is particularly high in people with hereditary pancreatitis who also smoke, use alcohol, have type 1 diabetes mellitus, or have a family history of cancer. In affected individuals who develop pancreatic cancer, it is typically diagnosed in mid-adulthood.

Complications from pancreatic cancer and type 1 diabetes mellitus are the most common causes of death in individuals with hereditary pancreatitis, although individuals with this condition are thought to have a normal life expectancy.

Frequency

Hereditary pancreatitis is thought to be a rare condition. In Europe, its prevalence is estimated to be 3 to 6 per million individuals.

Causes and Genetics

Mutations in the PRSS1 gene cause 65 to 80 percent of cases of hereditary pancreatitis. The remaining cases are caused by mutations in other genes, some of which have not been identified.

The PRSS1 gene provides instructions for making an enzyme called cationic trypsinogen. This enzyme is produced in the pancreas and helps with the digestion of food. When needed, it is secreted from the pancreas and transported to the small intestine, where it is cleaved into its active form, called trypsin. When digestion is complete, the enzyme is broken down.

Some PRSS1 gene mutations result in the production of a cationic trypsinogen enzyme that is prematurely converted to trypsin while still in the pancreas. Other mutations prevent trypsin from being broken down. These changes result in elevated levels of trypsin in the pancreas, which can damage pancreatic tissue and trigger an immune response, causing inflammation.

Other Genes Associated with Hereditary Pancreatitis

  • CFTR
  • CTRC
  • SPINK1

Inheritance Pattern

When caused by mutations in the PRSS1 gene, hereditary pancreatitis is inherited in an autosomal dominant pattern, meaning one copy of the altered gene in each cell is sufficient to cause the disorder. In some cases, an affected person inherits the mutation from a parent. Other cases result from new mutations in the gene and occur in people with no history of the disorder in their family.

It is estimated that 20 percent of people who have the altered PRSS1 gene never have an episode of pancreatitis. This situation is known as reduced penetrance. It remains unclear why some people with a mutated gene never develop signs and symptoms of the disease.

Other Names for This Condition

  • Autosomal dominant hereditary pancreatitis
  • Familial pancreatitis
  • Hereditary chronic pancreatitis
  • HP

Frequently Asked Questions

Pancreatic enzyme replacement therapy (PERT) with pancrelipase is the mainstay; dosing is adjusted based on the severity of steatorrhea and weight loss. High‑dose vitamin A, D, E, and K supplements are often required, and monitoring of fat‑soluble vitamin levels is essential. Regular follow‑up with a gastroenterologist ensures optimal dosing and nutritional status.
detailed family history is essential; if a first‑degree relative has had pancreatitis, genetic testing for common mutations (PRSS1, SPINK1, CFTR, CTRC) should be ordered. Imaging and laboratory workup to rule out gallstones, hypertriglyceridemia, and other causes are also performed. A positive genetic result confirms a hereditary basis.
Because the risk rises after age 30–35, annual surveillance with abdominal MRI or endoscopic ultrasound is recommended for adults over 30. For patients with more severe disease or additional risk factors, semi‑annual imaging may be advised. Early detection improves treatment options.
void high‑fat meals, especially fried or greasy foods, and limit alcohol entirely. Eating small, frequent meals, staying hydrated, and maintaining a healthy weight can reduce pancreatic stress. Some patients benefit from a low‑fat diet supplemented with pancreatic enzyme replacement if malabsorption occurs.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA